Clostridium difficile Webinar
Event Details
Originally Aired: Wedenesday, May 18, 2016
Time: 2 p.m. EST
Presenter: Erik R. Dubberke, MD, MSPH
Unless otherwise noted, P.A.C.E.™ accreditation will expire six months after the live webinar.
The incidence and severity of Clostridium difficile infection (CDI) has increased dramatically since 2000. In 2011, there were 453,000 CDI cases in the U.S. associated with more than 29,000 deaths*. The clinical microbiology laboratory plays a critical role in identifying patients who have CDI as well as the initiation of prevention measures. At the end of this Fisher HealthCare webinar, participants will understand how CDI impacts their patients, learn best practices for optimizing CDI diagnosis, and what can be done to prevent CDI.
Join Dr. Erik R. Dubberke as he discusses the public health concerns associated with Clostridium difficile and the role of the microbiology lab in the prevention and diagnosis of this potentially fatal infection.
Learn more and earn continuing education credits by attending this complimentary, PACE-accredited webinar.
*Source: National Foundation for Infectious Diseases
Presenter
Erik R Dubberke, MD, MSPH
Dr. Erik R. Dubberke is an Associate Professor of Medicine at Washington University School of Medicine in St. Louis, where he has been a faculty member in the Division of Infectious Diseases since 2005. He is an Associate Hospital Epidemiologist at Barnes-Jewish Hospital, Medical Director of Infection Control at Missouri Baptist Medical Center, and is the Director of the Section of Transplant Infectious Diseases at Washington University. He attended medical school at University of Illinois at Chicago, and did his medicine and infectious diseases training at Barnes-Jewish Hospital/Washington University. He received a Master of Science in Public Health from St. Louis University.
His main research interests are in the epidemiology, diagnosis, treatment and prevention of Clostridium difficile infection (CDI). He is the lead author of the CDI component of the SHEA compendium to prevent healthcare associated infections, and he’s a panel member on the update of the SHEA/IDSA CDI clinical guidelines.
Want to see how the Alere™ C. DIFF QUIK CHEK COMPLETE™ compares to your current testing protocol? Fill out the form to get a cost analysis of the Clostridium difficile algorithm, which provides more complete results than molecular testing alone.
This offer is only valid for those who have watched the webinar live or on-demand.